Jason Eugene Vice, OTR/L - Medicare Occupational Therapist in Birmingham, AL

Jason Eugene Vice, OTR/L is a medicare enrolled "Occupational Therapist" provider in Birmingham, Alabama. He graduated from medical school in 2015 and has 9 years of diverse experience with area of expertise as Occupational Therapy. He is a member of the group practice University Of Alabama At Birmingham and his current practice location is 1720 University Blvd, Suite 405, Birmingham, Alabama. You can reach out to his office (for appointments etc.) via phone at (205) 488-0736.

Jason Eugene Vice is licensed to practice in Alabama (license number 4153) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1073968020.

Contact Information

Jason Eugene Vice, OTR/L
1720 University Blvd, Suite 405,
Birmingham, AL 35233-1816
(205) 488-0736
(205) 488-0746



Healthcare Provider's Profile

Full NameJason Eugene Vice
GenderMale
SpecialityOccupational Therapy
Experience9 Years
Location1720 University Blvd, Birmingham, Alabama
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Jason Eugene Vice graduated from medical school in 2015
  NPI Data:
  • NPI Number: 1073968020
  • Provider Enumeration Date: 04/27/2016
  • Last Update Date: 02/15/2017
  Medicare PECOS Information:
  • PECOS PAC ID: 6103116579
  • Enrollment ID: I20160526001832

Medical Identifiers

Medical identifiers for Jason Eugene Vice such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1073968020NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225X00000XOccupational Therapist 4153 (Alabama)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
University Of Alabama At Birmingham377948797074

News Archive

Discovery reveals new role for endoplasmic reticulum-associated degradation

The discovery of a puddle of mouse urine seems like a strange scientific "eureka" moment. However, for one team of researchers, that's exactly what led to a new discovery.

NanoString's Prosigna Breast Cancer Assay can help identify node-positive early-stage breast cancer

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced new results from the combined data analysis of the Austrian Breast & Colorectal Cancer Study Group 8 (ABCSG-8) and Arimidex, Tamoxifen, Alone or in Combination studies.

WHO-International Atomic Energy Agency join forces to fight cancer in developing countries

WHO and the International Atomic Energy Agency (IAEA) today announced the launch of a Joint Programme on Cancer Control, aimed at strengthening and accelerating efforts to fight cancer in the developing world.

ICON, Proteome enter alliance to provide expanded biomarker solutions

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and Proteome Sciences a leading provider of protein biomarker discovery, validation, and assay development services, today announced the formation of a strategic alliance to provide pharmaceutical companies with an expanded biomarker solution to allow earlier assessments in the development of new medicines.

Study: More effective therapies needed for diabetes patients with ESRD

Despite significant advances in kidney care over the past 20 years, efforts to improve therapy for type 1 diabetes patients with kidney dysfunction remain unsuccessful, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The results suggest that more effective therapies are needed for these patients.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jason Eugene Vice allows following entities to bill medicare on his behalf.
Provider NameUniversity Of Alabama At Birmingham
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1184738478
PECOS PAC ID: 3779487970
Enrollment ID: O20031120000323

News Archive

Discovery reveals new role for endoplasmic reticulum-associated degradation

The discovery of a puddle of mouse urine seems like a strange scientific "eureka" moment. However, for one team of researchers, that's exactly what led to a new discovery.

NanoString's Prosigna Breast Cancer Assay can help identify node-positive early-stage breast cancer

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced new results from the combined data analysis of the Austrian Breast & Colorectal Cancer Study Group 8 (ABCSG-8) and Arimidex, Tamoxifen, Alone or in Combination studies.

WHO-International Atomic Energy Agency join forces to fight cancer in developing countries

WHO and the International Atomic Energy Agency (IAEA) today announced the launch of a Joint Programme on Cancer Control, aimed at strengthening and accelerating efforts to fight cancer in the developing world.

ICON, Proteome enter alliance to provide expanded biomarker solutions

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and Proteome Sciences a leading provider of protein biomarker discovery, validation, and assay development services, today announced the formation of a strategic alliance to provide pharmaceutical companies with an expanded biomarker solution to allow earlier assessments in the development of new medicines.

Study: More effective therapies needed for diabetes patients with ESRD

Despite significant advances in kidney care over the past 20 years, efforts to improve therapy for type 1 diabetes patients with kidney dysfunction remain unsuccessful, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The results suggest that more effective therapies are needed for these patients.

Read more Medical News

› Verified 4 days ago

Provider NameUniversity Of Alabama Ophthalmology Services Foundation
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1265485999
PECOS PAC ID: 9234023417
Enrollment ID: O20040210000034

News Archive

Discovery reveals new role for endoplasmic reticulum-associated degradation

The discovery of a puddle of mouse urine seems like a strange scientific "eureka" moment. However, for one team of researchers, that's exactly what led to a new discovery.

NanoString's Prosigna Breast Cancer Assay can help identify node-positive early-stage breast cancer

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced new results from the combined data analysis of the Austrian Breast & Colorectal Cancer Study Group 8 (ABCSG-8) and Arimidex, Tamoxifen, Alone or in Combination studies.

WHO-International Atomic Energy Agency join forces to fight cancer in developing countries

WHO and the International Atomic Energy Agency (IAEA) today announced the launch of a Joint Programme on Cancer Control, aimed at strengthening and accelerating efforts to fight cancer in the developing world.

ICON, Proteome enter alliance to provide expanded biomarker solutions

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and Proteome Sciences a leading provider of protein biomarker discovery, validation, and assay development services, today announced the formation of a strategic alliance to provide pharmaceutical companies with an expanded biomarker solution to allow earlier assessments in the development of new medicines.

Study: More effective therapies needed for diabetes patients with ESRD

Despite significant advances in kidney care over the past 20 years, efforts to improve therapy for type 1 diabetes patients with kidney dysfunction remain unsuccessful, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The results suggest that more effective therapies are needed for these patients.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jason Eugene Vice is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jason Eugene Vice, OTR/L
P.o. Box 830941, Msc 559,
Birmingham, AL 35283

Ph: (205) 325-8536
Jason Eugene Vice, OTR/L
1720 University Blvd, Suite 405,
Birmingham, AL 35233-1816

Ph: (205) 488-0736

News Archive

Discovery reveals new role for endoplasmic reticulum-associated degradation

The discovery of a puddle of mouse urine seems like a strange scientific "eureka" moment. However, for one team of researchers, that's exactly what led to a new discovery.

NanoString's Prosigna Breast Cancer Assay can help identify node-positive early-stage breast cancer

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced new results from the combined data analysis of the Austrian Breast & Colorectal Cancer Study Group 8 (ABCSG-8) and Arimidex, Tamoxifen, Alone or in Combination studies.

WHO-International Atomic Energy Agency join forces to fight cancer in developing countries

WHO and the International Atomic Energy Agency (IAEA) today announced the launch of a Joint Programme on Cancer Control, aimed at strengthening and accelerating efforts to fight cancer in the developing world.

ICON, Proteome enter alliance to provide expanded biomarker solutions

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and Proteome Sciences a leading provider of protein biomarker discovery, validation, and assay development services, today announced the formation of a strategic alliance to provide pharmaceutical companies with an expanded biomarker solution to allow earlier assessments in the development of new medicines.

Study: More effective therapies needed for diabetes patients with ESRD

Despite significant advances in kidney care over the past 20 years, efforts to improve therapy for type 1 diabetes patients with kidney dysfunction remain unsuccessful, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The results suggest that more effective therapies are needed for these patients.

Read more News

› Verified 4 days ago


Occupational Therapist in Birmingham, AL

Mccall Henger Christenson, OT
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 1600 5th Ave S, Birmingham, AL 35233
Phone: 205-939-9100    
Joseph Chase Bennett,
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 700 South 19th Street, 8305a - Office, Birmingham, AL 35233
Phone: 205-933-8101    
Lynn Paige Larkey, OTR/L
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 1600 7th Ave S, Pt/ot Dept 4nw, Birmingham, AL 35233
Phone: 205-939-9645    Fax: 205-939-6067
Mrs. Margiean Bridget Burks, OTR/L
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 1600 5th Ave S, Birmingham, AL 35233
Phone: 205-939-6296    Fax: 205-558-2077
Candace C Davis, O.T.
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 930 20th St S, Suite 101, Birmingham, AL 35205
Phone: 205-934-5471    Fax: 205-975-2380
Mrs. Anne Nehlig Walker, MS OTR/L
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 4778 Overton Rd, Birmingham, AL 35210
Phone: 205-957-0294    Fax: 205-957-0298
Anna Layne Wood, OTR
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 4778 Overton Rd, Birmingham, AL 35210
Phone: 205-957-0294    Fax: 205-957-0298

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.